Primary Intraocular Non-Hodgkin Lymphoma

Primary Intraocular Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

71 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: Aldeyra Therapeutics, Inc.
Termination share: 30.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04899453	Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL	unknown	Phase 2	42	Peking Union Medical College HospitalOTHER	1	May 24, 2021	clinicaltrials
NCT03746223	Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma	unknown	Phase 2	42	Peking Union Medical College HospitalOTHER	1	Oct 9, 2019	clinicaltrials